- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 790 N. Water Street Milwaukee WI United States of America 53202
- IPO Date
- Jun 2, 2014
- Business
- BMO Balanced Allocation Fund - Y (BGRYX) is a mutual fund managed by BMO Funds, Inc., part of BMO Asset Management, that seeks total investment return consisting of income and capital appreciation through a strategic asset allocation targeting approximately 40% equity and 60% fixed income exposure. The fund primarily invests in a diversified portfolio of other mutual funds and exchange-traded funds (ETFs) spanning U.S., Canadian, and international equity and fixed income securities; core holdings include U.S. equity funds, Canadian fixed income funds, Canadian equity funds, international equity funds, and U.S. fixed income funds, with typical allocations such as 22.7% U.S. equity, 22.0% Canadian fixed income, 15.1% Canadian equity, 14.0% international equity, and 11.0% U.S. fixed income as of recent reporting. It serves moderate-risk investors seeking balanced growth and income, with a minimum investment of $1,000, annual turnover around 20-60%, and monthly or annual distributions of net income, capital gains, and return of capital.
Launched with an inception date of May 30, 2014, the fund operates under BMO Investments Inc. as manager and BMO Asset Management Inc. as portfolio manager, with headquarters aligned to BMO Financial Group's U.S. operations in Chicago, Illinois, and broader global reach through BMO's Canadian base in Toronto, Ontario. Geographically, it provides exposure to North American, international, and emerging markets via underlying funds focused on equities and bonds in those regions.
In recent developments, BMO has pursued cost reductions across its asset allocation products, including lowered management fees on related balanced ETF portfolios like BMO Balanced ETF (ZBAL) effective June 2025, positioning them among Canada's lowest, alongside fee cuts for strategic yield funds in January 2025 and administration fee eliminations for select series in May 2025. While no specific mergers, acquisitions, or launches directly targeted BGRYX in 2024-2025, BMO announced tax-deferred mergers of target-date funds like BMO LifeStage Plus 2025 into money market and income portfolios in April 2025, and broader mutual fund line-up changes including risk rating adjustments in May 2024, reflecting ongoing portfolio optimization and investor value enhancements. These initiatives underscore BMO's strategic focus on fee competitiveness and product streamlining within its target risk and balanced allocation segments.